Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes ...
Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has become the first drug in the class to be approved in the EU for all adults with symptomatic chronic heart failure (CHF), giving ...
In a statement, Boehringer and Lilly said Jardiance is the first drug in the SGLT2 inhibitor class to achieve a statistically significant reduction in all-cause hospitalisations compared to ...